BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32782587)

  • 1. Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
    Yao H; Lv Y; Bai X; Yu Z; Liu X
    Oncol Lett; 2020 Sep; 20(3):2711-2720. PubMed ID: 32782587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma.
    Hao J; Gao X; Wang YP; Liu Q; Zhu H; Zhao SJ; Qin QH; Meng J; Li LL; Lin SC; Song Z; Li H
    Anticancer Drugs; 2022 Jun; 33(5):467-477. PubMed ID: 35276691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cryptic role of CXCL17/CXCR8 axis in the pathogenesis of cancers: a review of the latest evidence.
    Hashemi SF; Khorramdelazad H
    J Cell Commun Signal; 2023 Sep; 17(3):409-422. PubMed ID: 36352331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
    Park SJ; Lee SJ; Nam SY; Im DS
    Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of orphan GPCRs, GPR35 and GPR55.
    Shore DM; Reggio PH
    Front Pharmacol; 2015; 6():69. PubMed ID: 25926795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression.
    Li Y; Liu A; Liu S; Yan L; Yuan Y; Xu Q
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of the chemokine CXCL17 in colon cancer cells.
    Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B
    Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
    Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the IL-17 signalling pathway by the CXCL17-GPR35 axis affects drug resistance and colorectal cancer tumorigenesis.
    Bu J; Yan W; Huang Y; Lin K
    Am J Cancer Res; 2023; 13(5):2172-2187. PubMed ID: 37293165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What defines a chemokine? - The curious case of CXCL17.
    Giblin SP; Pease JE
    Cytokine; 2023 Aug; 168():156224. PubMed ID: 37210967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.
    Binti Mohd Amir NAS; Mackenzie AE; Jenkins L; Boustani K; Hillier MC; Tsuchiya T; Milligan G; Pease JE
    J Immunol; 2018 Jul; 201(2):714-724. PubMed ID: 29875152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.
    Gowhari Shabgah A; Jadidi-Niaragh F; Ebrahimzadeh F; Mohammadi H; Askari E; Pahlavani N; Malekahmadi M; Ebrahimi Nik M; Gholizadeh Navashenaq J
    Cell Biol Int; 2022 Oct; 46(10):1557-1570. PubMed ID: 35811438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Chemokines.
    Hernández-Ruiz M; Zlotnik A
    J Interferon Cytokine Res; 2017 Feb; 37(2):62-70. PubMed ID: 28207301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Unstable Angina and CXCL17: a New Potential Biomarker.
    Gong FH; Xiao XQ; Zhang XP; Long L; Huang S; Wang XS; Shu ZL; Yang YS
    Open Med (Wars); 2019; 14():939-944. PubMed ID: 31934638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal chemokine CXCL17: What is known and not known.
    Xiao S; Xie W; Zhou L
    Scand J Immunol; 2021 Feb; 93(2):e12965. PubMed ID: 32869346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
    Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
    PeerJ; 2018; 6():e4942. PubMed ID: 29915691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.